68Ga-FAPI imaging detects CAFs that are regulated by TGF-β signaling and shape the immunosuppressive TME, suggesting that 68Ga-FAPI PET is uniquely useful in monitoring the metastatic CRC response to combination therapy of TGF-β inhibitor and ICBs. The gene discussed is TGFB1; the disease is colorectal carcinoma.